Indian breast cancer diagnostics and therapeutics market are estimated to grow significantly at a CAGR of 11.1% during the forecast period. The major factors that are driving the market include the prevalence of breast cancer, awareness programs by government and private organizations in the country. Government agencies, NGOs and charity organizations have put great emphasis on improved breast cancer awareness among masses for promotion of early detection, providing comprehensive treatment module, providing support for breast cancer management and for screening and rehabilitation. The efforts have resulted in improved survival and quality of life of Indian breast cancer patients, however the improvement more pronounced in the urban population. The Extension for Community Healthcare Outcomes (ECHO) organizes breast cancer awareness and screening programs for rural and semi-urban Indian population. This project increased the cancer literacy amongst the rural population and awareness on early diagnosis of breast cancers and more public facilities for breast cancer treatments.

Indian breast cancer diagnostics and therapeutics market are segmented on the basis of cancer type, diagnostics, and therapeutics. In cancer type segment market is further classified into ductal carcinoma in-situ (DCIS), invasive ductal carcinoma (IDC), triple negative breast cancer (TNBC), inflammatory breast cancer and others. In diagnostics technology, the segment market is further classified into mammography, biopsy, position emission tomography/computed tomography, ultrasound, and others. The therapeutics technology segment market is further segregated into chemotherapy, hormone therapy, targeted therapy, and others. 

The companies which are contributing to the growth of the Indian breast cancer diagnostics and therapeutics market include, AstraZeneca PLC, Bayer AG, GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis International AG, F. Hoffmann-La Roche AG, Sun Pharmaceutical Industries Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market. 

Research Methodology

The market study of the Indian breast cancer diagnostics and therapeutics market is incorporated by extensive primary and secondary research conducted by the research team.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for biotechnology companies, research institutes, hospitals, and government organizations for the overall market and competitive analysis. The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Indian breast cancer diagnostics and therapeutics Market Research and Analysis by Cancer Type
2. Indian breast cancer diagnostics and therapeutics Market Research and Analysis by Diagnostics
3. Indian breast cancer diagnostics and therapeutics Market Research and Analysis by Therapeutics

The Report Covers

• Comprehensive research methodology of the Indian breast cancer diagnostics and therapeutics market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Indian breast cancer diagnostics and therapeutics market.
• Insights about market determinants which are stimulating the Indian breast cancer diagnostics and therapeutics market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.